| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 1.51e-05 | 2 | 78 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 1.51e-05 | 2 | 78 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 5.46e-05 | 441 | 78 | 9 | GO:0016887 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB6 CELSR1 ABCA12 CADM4 ARID2 FAT3 ITGA10 SLITRK3 NCK1 ACTL6B CTNNB1 IHH ITGAD ITGAM PCDH17 NCK2 | 2.20e-06 | 1077 | 78 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | bone remodeling | 8.65e-06 | 127 | 78 | 6 | GO:0046849 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB6 NF1 LINGO1 PLEKHG4 FAT3 ZNF335 TET1 KDR SLITRK3 NCK1 ACTL6B SRGAP2 GRIN1 FLRT2 CTNNB1 NCK2 | 2.05e-05 | 1285 | 78 | 16 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | EPHB6 NF1 LINGO1 PLEKHG4 FAT3 ZNF335 TET1 KDR SLITRK3 NCK1 ACTL6B SRGAP2 GRIN1 FLRT2 CTNNB1 IHH NCK2 | 2.63e-05 | 1463 | 78 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | negative regulation of oligodendrocyte differentiation | 4.08e-05 | 18 | 78 | 3 | GO:0048715 | |
| GeneOntologyBiologicalProcess | leukocyte proliferation | 4.56e-05 | 445 | 78 | 9 | GO:0070661 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 8.43e-05 | 4 | 78 | 2 | GO:0002017 | |
| GeneOntologyBiologicalProcess | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 8.43e-05 | 4 | 78 | 2 | GO:1903912 | |
| GeneOntologyBiologicalProcess | T cell proliferation | 1.09e-04 | 288 | 78 | 7 | GO:0042098 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 1.17e-04 | 202 | 78 | 6 | GO:0051963 | |
| GeneOntologyBiologicalProcess | lymphocyte proliferation | 1.29e-04 | 398 | 78 | 8 | GO:0046651 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB6 PLEKHG4 HPN FAT3 ZNF335 TET1 KDR SLITRK3 SRGAP2 GRIN1 FLRT2 CTNNB1 IHH IDUA | 1.38e-04 | 1194 | 78 | 14 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of translation in response to endoplasmic reticulum stress | 1.40e-04 | 5 | 78 | 2 | GO:0036493 | |
| GeneOntologyBiologicalProcess | mononuclear cell proliferation | 1.48e-04 | 406 | 78 | 8 | GO:0032943 | |
| GeneOntologyBiologicalProcess | synapse assembly | 1.65e-04 | 308 | 78 | 7 | GO:0007416 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 1.68e-04 | 309 | 78 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | 1.93e-04 | 538 | 78 | 9 | GO:0007264 | |
| GeneOntologyBiologicalProcess | glial cell migration | 2.41e-04 | 80 | 78 | 4 | GO:0008347 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 2.41e-04 | 80 | 78 | 4 | GO:0046850 | |
| GeneOntologyBiologicalProcess | synapse organization | NF1 SRGAP3 SLITRK3 SRGAP2 GRIN1 FLRT2 CTNNB1 ITGAM SEZ6L2 PCDH17 | 2.51e-04 | 685 | 78 | 10 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | NF1 SLC39A9 SRGAP3 KDR SLITRK3 SRGAP2 GRIN1 FLRT2 CTNNB1 ITGAM SEZ6L2 PCDH17 | 2.81e-04 | 974 | 78 | 12 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell junction assembly | 2.92e-04 | 569 | 78 | 9 | GO:0034329 | |
| GeneOntologyBiologicalProcess | T cell activation | 3.02e-04 | 701 | 78 | 10 | GO:0042110 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 3.18e-04 | 343 | 78 | 7 | GO:0090596 | |
| GeneOntologyBiologicalProcess | negative regulation of cartilage development | 3.40e-04 | 36 | 78 | 3 | GO:0061037 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal cell proliferation | 3.40e-04 | 36 | 78 | 3 | GO:0002053 | |
| GeneOntologyBiologicalProcess | negative regulation of PERK-mediated unfolded protein response | 3.90e-04 | 8 | 78 | 2 | GO:1903898 | |
| GeneOntologyBiologicalProcess | eiF2alpha phosphorylation in response to endoplasmic reticulum stress | 3.90e-04 | 8 | 78 | 2 | GO:0036492 | |
| GeneOntologyBiologicalProcess | regulation of translation initiation in response to endoplasmic reticulum stress | 3.90e-04 | 8 | 78 | 2 | GO:0036491 | |
| GeneOntologyBiologicalProcess | positive regulation of translation in response to stress | 3.90e-04 | 8 | 78 | 2 | GO:0032056 | |
| GeneOntologyBiologicalProcess | signal complex assembly | 3.90e-04 | 8 | 78 | 2 | GO:0007172 | |
| GeneOntologyBiologicalProcess | negative regulation of glial cell differentiation | 4.31e-04 | 39 | 78 | 3 | GO:0045686 | |
| GeneOntologyBiologicalProcess | regulation of long-term neuronal synaptic plasticity | 4.65e-04 | 40 | 78 | 3 | GO:0048169 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 4.74e-04 | 262 | 78 | 6 | GO:0048771 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 4.78e-04 | 171 | 78 | 5 | GO:0048593 | |
| GeneOntologyBiologicalProcess | bone resorption | 5.43e-04 | 99 | 78 | 4 | GO:0045453 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 5.56e-04 | 270 | 78 | 6 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cortisol biosynthetic process | 6.23e-04 | 10 | 78 | 2 | GO:0034651 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 6.23e-04 | 10 | 78 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | tertiary alcohol biosynthetic process | 6.23e-04 | 10 | 78 | 2 | GO:1902645 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 6.33e-04 | 385 | 78 | 7 | GO:0051251 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 6.53e-04 | 387 | 78 | 7 | GO:0050807 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 6.58e-04 | 45 | 78 | 3 | GO:0010464 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 7.36e-04 | 395 | 78 | 7 | GO:0050803 | |
| GeneOntologyBiologicalProcess | branching involved in blood vessel morphogenesis | 7.48e-04 | 47 | 78 | 3 | GO:0001569 | |
| GeneOntologyBiologicalProcess | aldosterone biosynthetic process | 7.60e-04 | 11 | 78 | 2 | GO:0032342 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 8.07e-04 | 290 | 78 | 6 | GO:0050870 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB6 PLEKHG4 ZNF335 TET1 KDR SLITRK3 SRGAP2 GRIN1 FLRT2 CTNNB1 | 8.60e-04 | 802 | 78 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | cortisol metabolic process | 9.09e-04 | 12 | 78 | 2 | GO:0034650 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 9.09e-04 | 12 | 78 | 2 | GO:1902237 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 9.15e-04 | 410 | 78 | 7 | GO:0031589 | |
| GeneOntologyBiologicalProcess | steroid hormone biosynthetic process | 9.51e-04 | 51 | 78 | 3 | GO:0120178 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB6 PLEKHG4 ZNF335 TET1 KDR SLITRK3 SRGAP2 GRIN1 FLRT2 CTNNB1 | 1.01e-03 | 819 | 78 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.06e-03 | 204 | 78 | 5 | GO:0048592 | |
| GeneOntologyBiologicalProcess | regulation of PERK-mediated unfolded protein response | 1.07e-03 | 13 | 78 | 2 | GO:1903897 | |
| GeneOntologyBiologicalProcess | regulation of translation in response to endoplasmic reticulum stress | 1.07e-03 | 13 | 78 | 2 | GO:0036490 | |
| GeneOntologyBiologicalProcess | mineralocorticoid biosynthetic process | 1.07e-03 | 13 | 78 | 2 | GO:0006705 | |
| GeneOntologyBiologicalProcess | regulation of Schwann cell migration | 1.07e-03 | 13 | 78 | 2 | GO:1900147 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | EPHB6 ARID2 ZNF335 NCK1 ACTL6B CTNNB1 IHH ITGAD ITGAM LEPR NCK2 | 1.07e-03 | 976 | 78 | 11 | GO:0046649 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB6 PLEKHG4 ZNF335 TET1 KDR SLITRK3 SRGAP2 GRIN1 FLRT2 CTNNB1 | 1.08e-03 | 826 | 78 | 10 | GO:0048858 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.10e-03 | 423 | 78 | 7 | GO:0002696 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 1.12e-03 | 54 | 78 | 3 | GO:0048013 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.19e-03 | 429 | 78 | 7 | GO:1902105 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.20e-03 | 313 | 78 | 6 | GO:0098742 | |
| GeneOntologyBiologicalProcess | Schwann cell migration | 1.25e-03 | 14 | 78 | 2 | GO:0036135 | |
| GeneOntologyBiologicalProcess | primary alcohol biosynthetic process | 1.25e-03 | 14 | 78 | 2 | GO:0034309 | |
| GeneOntologyBiologicalProcess | aldosterone metabolic process | 1.25e-03 | 14 | 78 | 2 | GO:0032341 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 1.28e-03 | 317 | 78 | 6 | GO:1903039 | |
| GeneOntologyBiologicalProcess | gliogenesis | 1.29e-03 | 435 | 78 | 7 | GO:0042063 | |
| GeneOntologyBiologicalProcess | developmental maturation | 1.36e-03 | 439 | 78 | 7 | GO:0021700 | |
| GeneOntologyBiologicalProcess | regulation of oligodendrocyte differentiation | 1.38e-03 | 58 | 78 | 3 | GO:0048713 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 1.42e-03 | 128 | 78 | 4 | GO:0034103 | |
| GeneOntologyBiologicalProcess | neuron migration | 1.42e-03 | 218 | 78 | 5 | GO:0001764 | |
| GeneOntologyBiologicalProcess | Schwann cell proliferation | 1.44e-03 | 15 | 78 | 2 | GO:0014010 | |
| GeneOntologyBiologicalProcess | peptidyl-serine dephosphorylation | 1.44e-03 | 15 | 78 | 2 | GO:0070262 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation by eIF2 alpha phosphorylation | 1.44e-03 | 15 | 78 | 2 | GO:0010998 | |
| GeneOntologyBiologicalProcess | mesenchymal cell proliferation | 1.45e-03 | 59 | 78 | 3 | GO:0010463 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.45e-03 | 59 | 78 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 1.54e-03 | 449 | 78 | 7 | GO:0050867 | |
| HumanPheno | Elevated serum 11-deoxycortisol | 1.36e-05 | 9 | 29 | 3 | HP:0025436 | |
| HumanPheno | Neoplasm of the endocrine system | 1.87e-05 | 155 | 29 | 7 | HP:0100568 | |
| HumanPheno | Increased circulating cortisol level | 2.73e-05 | 32 | 29 | 4 | HP:0003118 | |
| MousePheno | abnormal myocardium layer morphology | TNNI3K NF1 SYNM CYP11B1 CYP11B2 ARID2 ATP11A FLRT2 IDUA LEPR | 1.94e-05 | 414 | 65 | 10 | MP:0005329 |
| MousePheno | abnormal urine progesterone level | 2.13e-05 | 2 | 65 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 2.13e-05 | 2 | 65 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 2.13e-05 | 2 | 65 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 2.13e-05 | 2 | 65 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 2.13e-05 | 2 | 65 | 2 | MP:0011546 | |
| MousePheno | abnormal heart layer morphology | TNNI3K NF1 SYNM CYP11B1 CYP11B2 ARID2 ATP11A FLRT2 IDUA LEPR | 2.29e-05 | 422 | 65 | 10 | MP:0010545 |
| MousePheno | increased brain size | 4.58e-05 | 85 | 65 | 5 | MP:0005238 | |
| MousePheno | abnormal cardiac muscle tissue morphology | TNNI3K NF1 SYNM CYP11B1 CYP11B2 ARID2 ATP11A FLRT2 IDUA LEPR | 7.96e-05 | 489 | 65 | 10 | MP:0010630 |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 1.27e-04 | 4 | 65 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 1.27e-04 | 4 | 65 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 1.27e-04 | 4 | 65 | 2 | MP:0011539 | |
| MousePheno | abnormal urine corticosterone level | 1.27e-04 | 4 | 65 | 2 | MP:0011548 | |
| MousePheno | decreased urine hormone level | 1.27e-04 | 4 | 65 | 2 | MP:0014459 | |
| MousePheno | abnormal myocardial fiber morphology | 2.02e-04 | 183 | 65 | 6 | MP:0000278 | |
| MousePheno | increased adrenal gland zona fasciculata size | 2.11e-04 | 5 | 65 | 2 | MP:0014286 | |
| MousePheno | abnormal metabolism | NF1 HP SYNM ABCA12 CYP11B1 CYP11B2 TET1 IHH IDUA SLC25A19 ATP13A2 LEPR PPOX | 3.15e-04 | 936 | 65 | 13 | MP:0005266 |
| MousePheno | uterus adenomyosis | 3.16e-04 | 6 | 65 | 2 | MP:0009221 | |
| MousePheno | increased urine hormone level | 3.16e-04 | 6 | 65 | 2 | MP:0014458 | |
| MousePheno | adrenal gland hyperplasia | 3.16e-04 | 6 | 65 | 2 | MP:0009078 | |
| MousePheno | ocular hypertelorism | 3.22e-04 | 29 | 65 | 3 | MP:0001300 | |
| MousePheno | abnormal enzyme/coenzyme activity | 3.59e-04 | 287 | 65 | 7 | MP:0005584 | |
| MousePheno | increased susceptibility to otitis media | 3.93e-04 | 31 | 65 | 3 | MP:0001850 | |
| MousePheno | abnormal fluid intake | 4.19e-04 | 136 | 65 | 5 | MP:0011947 | |
| MousePheno | abnormal urine hormone level | 4.40e-04 | 7 | 65 | 2 | MP:0011538 | |
| MousePheno | pituitary gland hyperplasia | 4.40e-04 | 7 | 65 | 2 | MP:0000635 | |
| MousePheno | enlarged adrenal glands | 5.18e-04 | 34 | 65 | 3 | MP:0000642 | |
| MousePheno | increased circulating angiotensin II level | 5.85e-04 | 8 | 65 | 2 | MP:0031232 | |
| MousePheno | increased angiotensin II level | 5.85e-04 | 8 | 65 | 2 | MP:0031229 | |
| MousePheno | decreased cardiac output | 6.66e-04 | 37 | 65 | 3 | MP:0003393 | |
| Domain | NCK | 1.72e-05 | 2 | 78 | 2 | IPR017304 | |
| Domain | Cyt_P450_mitochondrial | 1.72e-05 | 2 | 78 | 2 | IPR002399 | |
| Domain | Integrin_alpha-2 | 5.47e-05 | 18 | 78 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 5.47e-05 | 18 | 78 | 3 | PF08441 | |
| Domain | Integrin_alpha | 5.47e-05 | 18 | 78 | 3 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 5.47e-05 | 18 | 78 | 3 | PS00242 | |
| Domain | Int_alpha_beta-p | 6.47e-05 | 19 | 78 | 3 | IPR013519 | |
| Domain | Int_alpha | 6.47e-05 | 19 | 78 | 3 | SM00191 | |
| Domain | FCH | 1.02e-04 | 22 | 78 | 3 | PF00611 | |
| Domain | FG_GAP | 1.02e-04 | 22 | 78 | 3 | PS51470 | |
| Domain | FCH | 1.02e-04 | 22 | 78 | 3 | SM00055 | |
| Domain | FCH_dom | 1.17e-04 | 23 | 78 | 3 | IPR001060 | |
| Domain | FG-GAP | 1.33e-04 | 24 | 78 | 3 | PF01839 | |
| Domain | FG-GAP | 1.33e-04 | 24 | 78 | 3 | IPR013517 | |
| Domain | F_BAR | 1.51e-04 | 25 | 78 | 3 | IPR031160 | |
| Domain | Integrin_dom | 1.51e-04 | 25 | 78 | 3 | IPR032695 | |
| Domain | F_BAR | 1.51e-04 | 25 | 78 | 3 | PS51741 | |
| Domain | Rho_GTPase_activation_prot | 5.03e-04 | 88 | 78 | 4 | IPR008936 | |
| Domain | SH3_1 | 6.18e-04 | 164 | 78 | 5 | PF00018 | |
| Domain | Integrin_alpha | 9.24e-04 | 11 | 78 | 2 | PF00357 | |
| Domain | ARM-like | 9.29e-04 | 270 | 78 | 6 | IPR011989 | |
| Domain | VWA | 1.66e-03 | 56 | 78 | 3 | PF00092 | |
| Domain | Integrin_alpha_C_CS | 1.99e-03 | 16 | 78 | 2 | IPR018184 | |
| Domain | SH3 | 2.10e-03 | 216 | 78 | 5 | SM00326 | |
| Domain | SH3 | 2.10e-03 | 216 | 78 | 5 | PS50002 | |
| Domain | RhoGAP | 2.22e-03 | 62 | 78 | 3 | SM00324 | |
| Domain | SH3_domain | 2.28e-03 | 220 | 78 | 5 | IPR001452 | |
| Domain | RhoGAP | 2.32e-03 | 63 | 78 | 3 | PF00620 | |
| Domain | - | 2.37e-03 | 222 | 78 | 5 | 1.25.10.10 | |
| Domain | RHOGAP | 2.43e-03 | 64 | 78 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 2.43e-03 | 64 | 78 | 3 | IPR000198 | |
| Domain | - | 2.43e-03 | 64 | 78 | 3 | 1.10.555.10 | |
| Domain | ARM-type_fold | 2.93e-03 | 339 | 78 | 6 | IPR016024 | |
| Domain | - | 3.12e-03 | 20 | 78 | 2 | 3.30.565.10 | |
| Domain | HEAT_REPEAT | 3.14e-03 | 70 | 78 | 3 | PS50077 | |
| Domain | HATPase_C | 3.43e-03 | 21 | 78 | 2 | IPR003594 | |
| Domain | VWFA | 4.90e-03 | 82 | 78 | 3 | PS50234 | |
| Domain | VWA | 5.24e-03 | 84 | 78 | 3 | SM00327 | |
| Domain | LRR_8 | 5.72e-03 | 171 | 78 | 4 | PF13855 | |
| Domain | CRAL-TRIO_dom | 6.07e-03 | 28 | 78 | 2 | IPR001251 | |
| Domain | Cys-rich_flank_reg_C | 6.34e-03 | 90 | 78 | 3 | IPR000483 | |
| Domain | LRRCT | 6.34e-03 | 90 | 78 | 3 | SM00082 | |
| Domain | Leu-rich_rpt_typical-subtyp | 6.45e-03 | 177 | 78 | 4 | IPR003591 | |
| Domain | LRR_TYP | 6.45e-03 | 177 | 78 | 4 | SM00369 | |
| Pathway | REACTOME_INACTIVATION_OF_CDC42_AND_RAC1 | 4.25e-06 | 8 | 61 | 3 | M27349 | |
| Pathway | KEGG_AXON_GUIDANCE | 1.92e-05 | 129 | 61 | 6 | M5539 | |
| Pathway | WP_GENES_CONTROLLING_NEPHROGENESIS | 3.78e-05 | 44 | 61 | 4 | M39891 | |
| Pathway | WP_HIPPOMERLIN_SIGNALING_DYSREGULATION | 1.74e-04 | 121 | 61 | 5 | M39823 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE | 1.83e-04 | 5 | 61 | 2 | M47522 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.87e-04 | 26 | 61 | 3 | M47 | |
| Pathway | WP_OREXIN_RECEPTOR_PATHWAY | 2.20e-04 | 200 | 61 | 6 | M48048 | |
| Pathway | PID_VEGFR1_2_PATHWAY | 2.22e-04 | 69 | 61 | 4 | M237 | |
| Pathway | WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING | 3.90e-04 | 144 | 61 | 5 | M39691 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 4.95e-04 | 85 | 61 | 4 | M16441 | |
| Pubmed | 1.13e-08 | 3 | 79 | 3 | 19137586 | ||
| Pubmed | Beta-Catenin Causes Adrenal Hyperplasia by Blocking Zonal Transdifferentiation. | 4.50e-08 | 4 | 79 | 3 | 32320669 | |
| Pubmed | β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer. | 4.50e-08 | 4 | 79 | 3 | 37129912 | |
| Pubmed | Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice. | 4.50e-08 | 4 | 79 | 3 | 32561853 | |
| Pubmed | β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis. | 4.50e-08 | 4 | 79 | 3 | 32245949 | |
| Pubmed | Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening. | 1.04e-07 | 50 | 79 | 5 | 19807924 | |
| Pubmed | SRGAP1 Controls Small Rho GTPases To Regulate Podocyte Foot Process Maintenance. | 2.24e-07 | 6 | 79 | 3 | 33514561 | |
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 12736724 | ||
| Pubmed | 2.24e-07 | 6 | 79 | 3 | 11672528 | ||
| Pubmed | A ZNRF3-dependent Wnt/β-catenin signaling gradient is required for adrenal homeostasis. | 3.92e-07 | 7 | 79 | 3 | 30692207 | |
| Pubmed | 3.92e-07 | 7 | 79 | 3 | 21655271 | ||
| Pubmed | Targeting NCK-Mediated Endothelial Cell Front-Rear Polarity Inhibits Neovascularization. | 6.27e-07 | 8 | 79 | 3 | 26659946 | |
| Pubmed | 9.38e-07 | 9 | 79 | 3 | 26362633 | ||
| Pubmed | 1.84e-06 | 11 | 79 | 3 | 18599507 | ||
| Pubmed | 2.45e-06 | 12 | 79 | 3 | 22919064 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23150505 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 5.09e-06 | 2 | 79 | 2 | 21164264 | |
| Pubmed | Fine tuning of the threshold of T cell selection by the Nck adapters. | 5.09e-06 | 2 | 79 | 2 | 21078909 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 33984363 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 8645611 | ||
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 5.09e-06 | 2 | 79 | 2 | 12231255 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20634641 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 1303253 | ||
| Pubmed | Hepsin enhances liver metabolism and inhibits adipocyte browning in mice. | 5.09e-06 | 2 | 79 | 2 | 32404422 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 31395659 | ||
| Pubmed | Nck adaptor proteins control the organization of neuronal circuits important for walking. | 5.09e-06 | 2 | 79 | 2 | 18093944 | |
| Pubmed | Nck adaptor proteins link Tks5 to invadopodia actin regulation and ECM degradation. | 5.09e-06 | 2 | 79 | 2 | 19596797 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 1741400 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 32540969 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26047574 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26324851 | ||
| Pubmed | A mouse model for the learning and memory deficits associated with neurofibromatosis type I. | 5.09e-06 | 2 | 79 | 2 | 9054942 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 7669222 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22271578 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22933298 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 2783417 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 5.09e-06 | 2 | 79 | 2 | 2256920 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 5.09e-06 | 2 | 79 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 5.09e-06 | 2 | 79 | 2 | 16396990 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23505444 | ||
| Pubmed | Nck adaptors are positive regulators of the size and sensitivity of the T-cell repertoire. | 5.09e-06 | 2 | 79 | 2 | 20709959 | |
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 5.09e-06 | 2 | 79 | 2 | 18397978 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 1518866 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 36035930 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23761669 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 5.09e-06 | 2 | 79 | 2 | 2592361 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 33141432 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 23314847 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 5.09e-06 | 2 | 79 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 5.09e-06 | 2 | 79 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 5.09e-06 | 2 | 79 | 2 | 15731365 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 10921920 | ||
| Pubmed | Distinct Requirements for Adaptor Proteins NCK1 and NCK2 in Mammary Gland Development. | 5.09e-06 | 2 | 79 | 2 | 37479911 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 17651452 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 34743356 | ||
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 5.09e-06 | 2 | 79 | 2 | 20339375 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 20808686 | ||
| Pubmed | Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair. | 5.09e-06 | 2 | 79 | 2 | 28254468 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 19242519 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 29242313 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 5.09e-06 | 2 | 79 | 2 | 21519965 | |
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 5.09e-06 | 2 | 79 | 2 | 21625068 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 16110193 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26066897 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21880263 | ||
| Pubmed | Nck adaptor proteins modulate differentiation and effector function of T cells. | 5.09e-06 | 2 | 79 | 2 | 25995205 | |
| Pubmed | Nck influences preosteoblastic/osteoblastic migration and bone mass. | 5.09e-06 | 2 | 79 | 2 | 26621720 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18651133 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22083159 | ||
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 5.09e-06 | 2 | 79 | 2 | 15699546 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18162527 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 38341019 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 24837548 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 30046010 | ||
| Pubmed | Familial and phenotypic associations of the aldosterone Renin ratio. | 5.09e-06 | 2 | 79 | 2 | 19820005 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 34926132 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 22622494 | ||
| Pubmed | Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. | 5.09e-06 | 2 | 79 | 2 | 15062555 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 17075030 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 17075029 | ||
| Pubmed | CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. | 5.09e-06 | 2 | 79 | 2 | 15507509 | |
| Pubmed | Polymorphism of CYP11B2 determines salt sensitivity in Japanese. | 5.09e-06 | 2 | 79 | 2 | 17296872 | |
| Pubmed | Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. | 5.09e-06 | 2 | 79 | 2 | 18039983 | |
| Pubmed | Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. | 5.09e-06 | 2 | 79 | 2 | 19029289 | |
| Pubmed | The phosphotyrosine peptide binding specificity of Nck1 and Nck2 Src homology 2 domains. | 5.09e-06 | 2 | 79 | 2 | 16636066 | |
| Pubmed | Necl-4 enhances the PLCγ-c-Raf-MEK-ERK pathway without affecting internalization of VEGFR2. | 5.09e-06 | 2 | 79 | 2 | 28601637 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 15522937 | ||
| Pubmed | Vegfa regulates perichondrial vascularity and osteoblast differentiation in bone development. | 8.98e-06 | 18 | 79 | 3 | 25977369 | |
| Pubmed | Nck-1 antagonizes the endoplasmic reticulum stress-induced inhibition of translation. | 1.53e-05 | 3 | 79 | 2 | 14676213 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 2546938 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 16118390 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 15469942 | ||
| Pubmed | Cooperative Interaction of Nck and Lck Orchestrates Optimal TCR Signaling. | 1.53e-05 | 3 | 79 | 2 | 33917227 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 25482634 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 17984374 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 29911835 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 2233742 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 1.47e-03 | 129 | 79 | 3 | chr2q35 | |
| Cytoband | 15q26.3 | 2.30e-03 | 41 | 79 | 2 | 15q26.3 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.60e-05 | 18 | 59 | 3 | 1160 | |
| GeneFamily | Cytochrome P450 family 11 | 3.13e-05 | 3 | 59 | 2 | 1007 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 5.58e-05 | 23 | 59 | 3 | 1288 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 5.80e-04 | 50 | 59 | 3 | 721 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-F_(Lymphatics)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.27e-06 | 194 | 79 | 6 | 9441202d6fa2ffbef9277d48ae9bc98876c26ec5 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-06 | 197 | 79 | 6 | c84e988c2ad06087aafda9e3b68e9e72fd0e75f1 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-06 | 197 | 79 | 6 | 6195f945b3fd6da07907619267d49e96d1044f8f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 165 | 79 | 5 | b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-05 | 165 | 79 | 5 | 28f8297ec7b781149cc7ac2f5e441771083b8ee3 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-05 | 173 | 79 | 5 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-05 | 173 | 79 | 5 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 179 | 79 | 5 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 179 | 79 | 5 | 479116ac65488c60104a053530830763ec1f95b2 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 179 | 79 | 5 | 1dfc0cb8b369aef35c59f3d4c52603dc9f3728c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 179 | 79 | 5 | 69a1b3b05c921de6343ffe6ad998aa2b804312a7 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 181 | 79 | 5 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.86e-05 | 183 | 79 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.96e-05 | 185 | 79 | 5 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 192 | 79 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-05 | 195 | 79 | 5 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-05 | 195 | 79 | 5 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.72e-05 | 198 | 79 | 5 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.78e-05 | 199 | 79 | 5 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.78e-05 | 199 | 79 | 5 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.78e-05 | 199 | 79 | 5 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 199 | 79 | 5 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.78e-05 | 199 | 79 | 5 | 6cfefd81e8a1a883fb4279ac4ab0b298ed2a0817 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.78e-05 | 199 | 79 | 5 | 1029f3458b7fda464aa0e7ef06e081e2618c1388 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Neuronal-PNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.78e-05 | 199 | 79 | 5 | 8a04398653a1794921d73a6a950c1fb6fdf68c85 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.85e-05 | 200 | 79 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 7.49e-05 | 126 | 79 | 4 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Car3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.51e-05 | 134 | 79 | 4 | 4ef5f395e321cf04e56560be2502a8aa157682f4 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 55 | 79 | 3 | 0b62b4f438a493a30bddb99e1eadd20c92704ee9 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.28e-04 | 55 | 79 | 3 | fa556ea954ea868a4b23e410f3b27d69e04794ee | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 1.43e-04 | 149 | 79 | 4 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.79e-04 | 158 | 79 | 4 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | Club-club-16|World / Class top | 2.12e-04 | 165 | 79 | 4 | 684f3c4872bd630d3f744f15d57dccfd34e96160 | |
| ToppCell | 15-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.12e-04 | 165 | 79 | 4 | 531804467601e1ee1f771cffa21501f6d464ae10 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.12e-04 | 165 | 79 | 4 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.27e-04 | 168 | 79 | 4 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 170 | 79 | 4 | b180ec9a1b79025a180c8559c27c31272410dea8 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 170 | 79 | 4 | 749144a1a869a6bf9acdd227184319083367dc3f | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 170 | 79 | 4 | 37c647f67505aa1ff12a198df1eeddd9f406fe15 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-04 | 170 | 79 | 4 | 25d60a62e8f99c31ab64fe6a0c07ccca3df1a7ee | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-04 | 172 | 79 | 4 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-04 | 172 | 79 | 4 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 175 | 79 | 4 | 3f1b2e23fec953148fb0711e523c463adb07dca4 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 175 | 79 | 4 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 2.70e-04 | 176 | 79 | 4 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.76e-04 | 177 | 79 | 4 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.76e-04 | 177 | 79 | 4 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-04 | 179 | 79 | 4 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | facs-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-04 | 179 | 79 | 4 | bbfbfb32773346080127055b5aafa36bbf7d0942 | |
| ToppCell | NS-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.88e-04 | 179 | 79 | 4 | 65a96bee7bc28f5bfc20f0fd92bcc0ab2eb5e06c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 181 | 79 | 4 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-04 | 181 | 79 | 4 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 181 | 79 | 4 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 181 | 79 | 4 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-04 | 181 | 79 | 4 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 3.01e-04 | 181 | 79 | 4 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.01e-04 | 181 | 79 | 4 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|normal_Lung / Location, Cell class and cell subclass | 3.07e-04 | 182 | 79 | 4 | 13c39228f76495deca6b948483bbde426b3e8c5b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.07e-04 | 182 | 79 | 4 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.07e-04 | 182 | 79 | 4 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 182 | 79 | 4 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | (6)_Endothelial-F_(Lymphatics)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.20e-04 | 184 | 79 | 4 | 03ea613e00b45c81b752c14505a0538d698f551e | |
| ToppCell | Endothelial-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 3.34e-04 | 186 | 79 | 4 | 796cbae2a417502aaf0891fc9c382bbfd88967fe | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.34e-04 | 186 | 79 | 4 | bdbe290f81106a53c8c30a92fbb385597c62b2ac | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 186 | 79 | 4 | 7a8da2ad140bea3207bd868212cc5e201d586772 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.34e-04 | 186 | 79 | 4 | dc394034929c6b10ae0e1c1a028cc3d4ce873298 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.34e-04 | 186 | 79 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.40e-04 | 187 | 79 | 4 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.40e-04 | 187 | 79 | 4 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 187 | 79 | 4 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.40e-04 | 187 | 79 | 4 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 3.47e-04 | 188 | 79 | 4 | e711c7a46d7cfa030ca2982eacc1dae5af5788dd | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-04 | 188 | 79 | 4 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.47e-04 | 188 | 79 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-04 | 188 | 79 | 4 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.47e-04 | 188 | 79 | 4 | 5707786cc4452dc34f95db2b3cd29f6e025c0622 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-04 | 188 | 79 | 4 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-04 | 188 | 79 | 4 | fe7143c36e4a883745862d3c3147cf751b440e46 | |
| ToppCell | Endothelial-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.47e-04 | 188 | 79 | 4 | ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-04 | 188 | 79 | 4 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-04 | 188 | 79 | 4 | cbf32b675a7cd0c808d5c9c22dfa7fa79fbe2437 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.47e-04 | 188 | 79 | 4 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 3.47e-04 | 188 | 79 | 4 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 3.54e-04 | 189 | 79 | 4 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 3.54e-04 | 189 | 79 | 4 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 189 | 79 | 4 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 189 | 79 | 4 | 1137583e21d874c201c20581ba1995e2bfa3de59 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 3.62e-04 | 190 | 79 | 4 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | droplet-Heart-nan-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 190 | 79 | 4 | 7068754c29f63a331e2b6c54715f3b26f37ad32b | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 3.62e-04 | 190 | 79 | 4 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 190 | 79 | 4 | 0bad41d19dc515e6bc61e699f4d56664cf2e72fd | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 3.69e-04 | 191 | 79 | 4 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 3.69e-04 | 191 | 79 | 4 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 191 | 79 | 4 | 1aac4f839c2f83dac924fdb5d8d0c76687dacd2a | |
| ToppCell | LA-05._Cytoplasmic_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.69e-04 | 191 | 79 | 4 | d825e55278dce666c332cc060d1255659e07e568 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.69e-04 | 191 | 79 | 4 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.76e-04 | 192 | 79 | 4 | 5af3b2b38495e925497c48f605d618bbf970965d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.76e-04 | 192 | 79 | 4 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.76e-04 | 192 | 79 | 4 | 9da21ce330f3b5661f159cf18d1c3e5ccc11d6dd | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.76e-04 | 192 | 79 | 4 | 89b8ebdc285ed3c0f807fd1157271130d37dfa41 | |
| Drug | Ethopropazine hydrochloride [1094-08-2]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 5.13e-06 | 197 | 78 | 7 | 3376_UP | |
| Drug | deguelin | 7.65e-06 | 137 | 78 | 6 | ctd:C107676 | |
| Drug | 3,4,5,3',4',5'-hexachlorobiphenyl | 1.08e-05 | 13 | 78 | 3 | ctd:C027309 | |
| Drug | cyadox | 1.16e-05 | 2 | 78 | 2 | ctd:C020728 | |
| Drug | 18-hydroxydeoxycorticosterone | 1.16e-05 | 2 | 78 | 2 | ctd:C042509 | |
| Drug | 1y0l | 3.04e-05 | 18 | 78 | 3 | CID000657047 | |
| Drug | 18-hydroxycortisol | 3.47e-05 | 3 | 78 | 2 | ctd:C033689 | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 5.01e-05 | 191 | 78 | 6 | 5456_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 5.47e-05 | 194 | 78 | 6 | 3859_DN | |
| Drug | Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; PC3; HT_HG-U133A | 5.79e-05 | 196 | 78 | 6 | 7257_DN | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 5.79e-05 | 196 | 78 | 6 | 2243_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 5.95e-05 | 197 | 78 | 6 | 6233_UP | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Up 200; 21.4uM; PC3; HT_HG-U133A | 6.29e-05 | 199 | 78 | 6 | 6699_UP | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 6.29e-05 | 199 | 78 | 6 | 6872_UP | |
| Drug | F-OH | 6.51e-05 | 63 | 78 | 4 | CID000123334 | |
| Drug | methenamine silver | 6.65e-05 | 201 | 78 | 6 | CID000004101 | |
| Drug | C05489 | 6.92e-05 | 4 | 78 | 2 | CID000440708 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 6.90e-06 | 2 | 78 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | Glucocorticoid-remediable aldosteronism | 6.90e-06 | 2 | 78 | 2 | C1260386 | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 2.07e-05 | 3 | 78 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | Albuminuria | 3.46e-05 | 24 | 78 | 3 | C0001925 | |
| Disease | apolipoprotein L1 measurement | 3.92e-05 | 25 | 78 | 3 | EFO_0021854 | |
| Disease | pre-eclampsia (is_implicated_in) | 3.92e-05 | 25 | 78 | 3 | DOID:10591 (is_implicated_in) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 6.86e-05 | 5 | 78 | 2 | DOID:446 (is_implicated_in) | |
| Disease | Conn Syndrome | 1.03e-04 | 6 | 78 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 1.03e-04 | 6 | 78 | 2 | C0020428 | |
| Disease | Malignant neoplasm of breast | NF1 HP SRGAP3 NUP98 MROH7 KDR DHX32 CTNNB1 FASTKD3 LEPR INPP4B | 1.18e-04 | 1074 | 78 | 11 | C0006142 |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 1.30e-04 | 97 | 78 | 4 | DOID:3083 (is_marker_for) | |
| Disease | triglyceride measurement, C-reactive protein measurement | 1.40e-04 | 38 | 78 | 3 | EFO_0004458, EFO_0004530 | |
| Disease | protocadherin alpha-7 measurement | 1.44e-04 | 7 | 78 | 2 | EFO_0801973 | |
| Disease | protein FAM163B measurement | 2.45e-04 | 9 | 78 | 2 | EFO_0802936 | |
| Disease | systemic lupus erythematosus | LINGO1 SRGAP3 RALGPS2 SRGAP2 STEAP1B SLC25A19 ITGAM SEZ6L2 NCK2 | 2.57e-04 | 799 | 78 | 9 | MONDO_0007915 |
| Disease | hypertension (is_implicated_in) | 3.04e-04 | 121 | 78 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | androstenedione measurement | 3.06e-04 | 10 | 78 | 2 | EFO_0007972 | |
| Disease | Machado-Joseph disease, age at onset | 3.74e-04 | 11 | 78 | 2 | EFO_0004847, MONDO_0007182 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0021862 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 3.74e-04 | 11 | 78 | 2 | EFO_0801461 | |
| Disease | bitter alcoholic beverage consumption measurement | 4.35e-04 | 133 | 78 | 4 | EFO_0010092 | |
| Disease | Colorectal Carcinoma | 5.34e-04 | 702 | 78 | 8 | C0009402 | |
| Disease | schizophrenia (implicated_via_orthology) | 7.87e-04 | 68 | 78 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | Hemangiosarcoma | 1.03e-03 | 18 | 78 | 2 | C0018923 | |
| Disease | Intellectual Disability | 1.20e-03 | 447 | 78 | 6 | C3714756 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 1.23e-03 | 301 | 78 | 5 | DOID:684 (is_marker_for) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.37e-03 | 181 | 78 | 4 | DOID:684 (is_implicated_in) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 1.40e-03 | 21 | 78 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | serum iron measurement | 1.55e-03 | 86 | 78 | 3 | EFO_0006332 | |
| Disease | Dyslipidemias | 1.83e-03 | 24 | 78 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 1.83e-03 | 24 | 78 | 2 | C0598784 | |
| Disease | Endogenous Hyperinsulinism | 2.15e-03 | 26 | 78 | 2 | C1257963 | |
| Disease | Exogenous Hyperinsulinism | 2.15e-03 | 26 | 78 | 2 | C1257964 | |
| Disease | Compensatory Hyperinsulinemia | 2.15e-03 | 26 | 78 | 2 | C1257965 | |
| Disease | Schizophrenia | 2.30e-03 | 883 | 78 | 8 | C0036341 | |
| Disease | Nephrotic Syndrome | 2.32e-03 | 27 | 78 | 2 | C0027726 | |
| Disease | Hyperinsulinism | 2.49e-03 | 28 | 78 | 2 | C0020459 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QEVYNVGIHGPFLVI | 851 | Q9HCK8 | |
| IHQVLEAPGVYVFGE | 31 | Q9UBW8 | |
| PVVITLQHIGGNQNY | 2666 | Q8IZF6 | |
| LEYHVPVTAGGVANI | 2521 | Q86UK0 | |
| AIPVHDGYVLQQGIV | 176 | O94805 | |
| GQTYAPAIHQIVLAN | 936 | Q68CP9 | |
| LCGYPQLVTQVHVLG | 511 | O15484 | |
| ENVPLGYPVVHIQAV | 576 | Q9NYQ6 | |
| VNIGHEVGYVIPFEN | 136 | Q7L7V1 | |
| IPEGVTVLYLHNNQI | 61 | O43155 | |
| YVLGQLQHEAAVPQL | 211 | Q9BU89 | |
| GRVPTQQEAYQVHVG | 411 | Q8NE62 | |
| IQVHYHIGLNLPGCV | 871 | Q68CQ1 | |
| VHENNIPGEYLGSVL | 481 | O14917 | |
| GVYPPIQVHVTLGNE | 296 | Q15118 | |
| AQNAVRLHYGLPVVV | 481 | P35222 | |
| LIVPNLGVAVIHDYA | 1236 | P52948 | |
| VVLHPNYSQVDIGLI | 236 | P00738 | |
| LNTGQVLHVVQALYP | 186 | P16333 | |
| GQGSRVLHVVQTLYP | 191 | O43639 | |
| GQLLHVYPVLFNVGI | 736 | O15327 | |
| ARGIDIHGVPYVINV | 576 | Q92499 | |
| IIGYVGEHGETVNIP | 286 | Q9HCR9 | |
| GLIIIQHGPYLQITH | 41 | Q8IXQ8 | |
| HQSDAGLYVIVPVII | 836 | P48357 | |
| IQLVGGQLAVVEPYA | 316 | Q96FE5 | |
| VLVQQIVPVYGHFRV | 4946 | P98088 | |
| SPHGLQLGVQAVVYH | 226 | P05981 | |
| VQNLVLGAPRYQHTG | 416 | Q13349 | |
| IVYHLARQGNGPVLV | 516 | Q92900 | |
| LQARAYVGPHVLAVV | 381 | Q9NQ11 | |
| PGHVILEQYQANVGA | 1306 | Q86XA9 | |
| AGVALLNDHIYVVGG | 466 | Q53G59 | |
| QHIYQPLNLTIGVTV | 101 | Q8N5D6 | |
| GVSIRVQGIDGHPYI | 41 | Q0VF96 | |
| VQGIDGHPYIVLNNT | 46 | Q0VF96 | |
| RPVVVPNIQAGHSYV | 4136 | Q8TDW7 | |
| GHTNIVEYLIQEQPG | 226 | Q9BSK4 | |
| VLQNYHIPAGTLVRV | 391 | P15538 | |
| LHQYDGSIVVIQNPA | 46 | Q8NFZ8 | |
| QLNLAYVGAVPHRGI | 71 | P35475 | |
| IHQAVRLYNLPGVEG | 851 | P49641 | |
| QIQVGLVQYGESPVH | 201 | O75578 | |
| VLQNYHIPAGTLVQV | 391 | P19099 | |
| YAQPLVGGIVGTLHQ | 621 | Q96PD2 | |
| VIYVLSTPAHIQIGD | 236 | Q6UWP2 | |
| YVATVHVLPEVGGIG | 256 | Q9NUM3 | |
| SHVQPGQYVLVAGVP | 296 | Q14623 | |
| PHFGDIQEGIYVAIQ | 21 | Q8N4N8 | |
| VHLYPGAVTIQGVLR | 451 | Q86X27 | |
| GHQIPGYIHILVANL | 266 | Q8NH60 | |
| AVVITGVQPEHIQYL | 321 | A6NHR9 | |
| NGIDGLVPHQYIVVQ | 786 | Q7Z6B7 | |
| RIIVHPNYVTAGLGA | 146 | A6NIE9 | |
| TQQIVYHGLVPQLGE | 1321 | O15061 | |
| YLHSNNIVVVPEAIG | 71 | Q86X40 | |
| QEAAPGAVYQVLLVG | 271 | Q58EX7 | |
| LLGYQVVQIPYHEIG | 621 | Q14CZ7 | |
| RAHVPYILEVQAVNG | 451 | O15197 | |
| YLPVAGVLEHLNAIV | 541 | O94933 | |
| IHVYPGYGIEIQVQT | 206 | Q6UXD5 | |
| VQSLVLGAPRYQHIG | 416 | P11215 | |
| HYIIVVGFNNPQLLA | 221 | Q6Q759 | |
| YLPGVIAAIVQVHNG | 111 | Q6NZ63 | |
| VSYGLAVQGAIQILP | 456 | Q8NFU7 | |
| IEGHVYVPHVICNGQ | 431 | P98196 | |
| VVNLQYQGAHLPVQG | 316 | P50336 | |
| HNGVDGLIPHQYIVV | 786 | O43295 | |
| NGIDGLIPHQYIVVQ | 771 | O75044 | |
| NLLNPIHGIVQSVVY | 2676 | P21359 | |
| PVIIGVVQGINYILG | 311 | Q9H920 | |
| LVYHVVGVDVGFENP | 166 | Q15393 | |
| LPNVVVNGVLQGLYS | 156 | Q96L94 | |
| VSLVVHYNTGGIPRI | 36 | Q86T82 | |
| HVVSLVVYVPPQIGE | 411 | P35968 | |
| PVQVVTHGLLGIYQE | 361 | P52888 | |
| DIQQVGYGGLTALHI | 126 | Q59H18 | |
| DGVQHLLPQEYVVVP | 1231 | Q9H4Z2 | |
| YVVVPEGHHIQVQEG | 1241 | Q9H4Z2 | |
| GHVPAQILSIGYGAV | 81 | Q9HC21 | |
| LVQVGIYNGTHVIPN | 361 | Q05586 |